Dr. Christina Davies of the University of Oxford in England and other researchers assigned 6,846 women who already had taken tamoxifen for five years to either stay on it or take dummy pills for another five years.
Date: Dec 05, 2012
Category: Health
Source: Google
Breast Cancer: Tamoxifen Saves Lives but Some Women Go Without It
"It is an extraordinary drug in terms of the protection it offers women in the decade after treatment," said Christina Davies, a senior research scientist at the Clinical Trial Service Unit at Oxford University and the study's lead author. "It's off-patent, it's cheap and it's available to women wo
Date: Jul 29, 2011
Category: Health
Source: Google
Five Years of Tamoxifen Lowers 15-Year Mortality, Recurrence
Christina Davies, B.M.B.Ch., from the Clinical Trial Service Unit in Oxford, U.K., and colleagues reviewed individual patient data from 20 trials relating the effects of tamoxifen on early breast cancer, to quantify hormone receptor levels, use of chemotherapy, and other factors. The study analyzed
"Substantially reduced mortality rates for breast cancer continue well beyond year 10, as a delayed effect of the greatly reduced [breast cancer] recurrence rates during years 0 to 9 [after about five years of tamoxifen therapy]," report Christina Davies, MD, and colleagues in the international Earl
Date: Jul 29, 2011
Category: Health
Source: Google
Tamoxifen Wards Off Breast Cancer's Return for More Than a Decade
"It's a remarkable drug," said study author Dr. Christina Davies, a lead investigator with the Early Breast Cancer Trialists Collaborative Group, which was established some 25 years ago to conduct periodic reviews of research on breast cancer from around the world. "It has probably saved more lives